18 results on '"Nakashima, J."'
Search Results
2. MP-08.11
- Author
-
Ohigashi, T., primary, Uchida, Y., additional, Kikuchi, E., additional, Miyajima, A., additional, Nakashima, J., additional, and Murai, M., additional
- Published
- 2006
- Full Text
- View/download PDF
3. MP-12.10
- Author
-
Horiguchi, Y., primary, Kosugi, M., additional, Kikuchi, E., additional, Miyajima, A., additional, Nakashima, J., additional, Murai, M., additional, Umezawa, K., additional, and Tachibana, M., additional
- Published
- 2006
- Full Text
- View/download PDF
4. Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical Cystectomy.
- Author
-
Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, Namiki K, Yoshioka K, Ohori M, Hatano T, and Tachibana M
- Published
- 2012
5. Prognostic value of alkaline phosphatase flare in patients with metastatic prostate cancer treated with endocrine therapy
- Author
-
Nakashima, J., Ozu, C., Nishiyama, T., Oya, M., Ohigashi, T., Asakura, H., Tachibana, M., and Murai, M.
- Published
- 2000
- Full Text
- View/download PDF
6. MP-12.10: Therapeutic impact of NF-kB Inhibitor against human bladder cancer in murine xenograft model
- Author
-
Horiguchi, Y., Kosugi, M., Kikuchi, E., Miyajima, A., Nakashima, J., Murai, M., Umezawa, K., and Tachibana, M.
- Published
- 2006
- Full Text
- View/download PDF
7. MP-08.11: Vitamin E succinate inactivates androgen receptor and enhances the cytotoxic effects of paclitaxel in prostate cancer cells
- Author
-
Ohigashi, T., Uchida, Y., Kikuchi, E., Miyajima, A., Nakashima, J., and Murai, M.
- Published
- 2006
- Full Text
- View/download PDF
8. Primitive Neuroectodermal Tumor of the Retroperitoneal Cavity
- Author
-
Horiguchi, Y., Nakashima, J., Ishii, T., and Hata, J.-I.
- Published
- 1994
- Full Text
- View/download PDF
9. Late recurrence and progression in non-muscle-invasive bladder cancers after 5-year tumor-free periods.
- Author
-
Matsumoto K, Kikuchi E, Horiguchi Y, Tanaka N, Miyajima A, Nakagawa K, Nakashima J, and Oya M
- Published
- 2010
- Full Text
- View/download PDF
10. Prediction of multifocal lesions in patients with upper tract urothelial carcinoma.
- Author
-
Hashimoto T, Ohno Y, Nakashima J, Gondo T, Yoshioka K, Ohori M, and Tachibana M
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Carcinoma, Transitional Cell pathology, Kidney Neoplasms pathology, Kidney Pelvis, Ureteral Neoplasms pathology
- Abstract
Objective: To identify predictive factors for multifocal lesions in patients with upper tract urothelial carcinoma (UTUC)., Patients and Methods: Between June 1996 and September 2013, a cohort of 147 patients underwent radical nephroureterectomy at our institution. Univariate and multivariate logistic regression analyses were performed to identify clinical covariates significantly associated with the multifocal UTUC lesions and establish a model to predict its occurrence., Results: In the univariate analyses, estimated glomerular filtration rate, hydronephrosis, history of bladder cancer, hemoglobin level, and Brinkman index were significantly associated with multifocal lesions. In the multivariate analysis, hydronephrosis (P = .010), history of bladder cancer (P = .017), Brinkman index >100 (P = .014), and hemoglobin level <11 g/dL (P = .031) were independent predictive factors for multifocal lesions. Using these independent factors, we calculated the predictive probability of multifocal lesions and predicted their occurrence. The predictive probability of multifocal lesions strongly correlated with their observed rate (regression coefficient = 0.9999)., Conclusion: An improved understanding of UTUC has led to various clinical guidelines being revised to recommend less invasive interventions in appropriate cases. Hydronephrosis, history of bladder cancer, Brinkman index, and hemoglobin level are independent predictive factors for multifocal lesions of UTUC. Although this study has limitations and additional studies are required to validate our findings, this information may aid in appropriate patient selection for partial ureterectomy and may be effectively incorporated into clinical practice., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
11. Clinical implications of preoperative serum total cholesterol in patients with clear cell renal cell carcinoma.
- Author
-
Ohno Y, Nakashima J, Nakagami Y, Gondo T, Ohori M, Hatano T, and Tachibana M
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Preoperative Care, Prognosis, Retrospective Studies, Young Adult, Carcinoma, Renal Cell blood, Carcinoma, Renal Cell surgery, Cholesterol blood, Kidney Neoplasms blood, Kidney Neoplasms surgery, Nephrectomy
- Abstract
Objective: To investigate the clinical implication of preoperative serum total cholesterol (TC) level in patients with clear cell renal cell carcinoma (RCC)., Methods: The records of 364 patients with clear cell RCC who had undergone nephrectomy were retrospectively reviewed. The association among preoperative TC level, clinicopathologic factors, and oncological outcome in terms of cancer-specific survival (CSS) and recurrence-free survival period was analyzed by univariate and multivariate analyses., Results: As a continuous variable, lower serum TC level was found to be significantly associated with male sex, symptomatic tumor, advanced TNM stage, higher nuclear grade, microscopic venous invasion, poor Eastern Cooperative Oncology Group Performance Status, larger tumor size, elevated C-reactive protein level, and lower hemoglobin level. Univariate analysis showed that relatively lower preoperative serum TC level was associated with lower recurrence-free survival (P = .040) and CSS (P <.001) rates. Multivariate analysis indicated that in addition to pT stage, M stage, nuclear grade, and Eastern Cooperative Oncology Group Performance Status, serum TC level (hazard ratio, 0.988 per mg/dL; 95% confidence interval, 0.980-0.998; P = .019) was an independent predictor of CSS., Conclusion: Low preoperative serum TC level is associated with worse prognosis in patients with clear cell RCC. Consideration of preoperative serum TC level might thus provide additional prognostic information for patients with clear cell RCC., (Crown Copyright © 2014. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
12. Clinical implications of tumor size and local extent of primary prostatic lesions in prostate cancer patients with metastases: value of endorectal magnetic resonance imaging in patients with metastases.
- Author
-
Nakashima J, Tanimoto A, Kikuchi E, Miyajima A, Nakagawa K, Oya M, Ohigashi T, and Murai M
- Subjects
- Humans, Male, Rectum, Retrospective Studies, Adenocarcinoma pathology, Adenocarcinoma secondary, Magnetic Resonance Imaging methods, Prostatic Neoplasms pathology
- Abstract
Objectives: To investigate the clinical significance of local assessment by endorectal magnetic resonance imaging (MRI) in prostate cancer patients with metastases., Methods: The local extent and tumor size were determined by endorectal MRI in 95 prostate cancer patients with metastases, and their clinical implications were assessed., Results: The maximum diameter and tumor volume significantly correlated with the local extent of disease but not with extent of disease (EOD) on bone scan. In univariate analyses, EOD, serum prostate-specific antigen level, serum alkaline phosphatase level, and hemoglobin level were significantly associated with disease-specific survival, whereas tumor size and local extent of primary lesions were not. In a multivariate analysis EOD on bone scan was a significant prognostic factor., Conclusions: Tumor size and local extent of the primary lesion estimated by endorectal MRI were not associated with disease-specific survival. Assessment of the primary lesion by endorectal MRI is of limited value in predicting the prognosis of prostate cancer patients with metastases.
- Published
- 2007
- Full Text
- View/download PDF
13. Interleukin 6 is associated with cachexia in patients with prostate cancer.
- Author
-
Kuroda K, Nakashima J, Kanao K, Kikuchi E, Miyajima A, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, and Murai M
- Subjects
- Humans, Male, Retrospective Studies, Cachexia blood, Cachexia etiology, Interleukin-6 blood, Prostatic Neoplasms blood, Prostatic Neoplasms complications
- Abstract
Objectives: To evaluate the relationship between serum interleukin (IL)-6 and cachexia in patients with prostate cancer., Methods: Serum levels of IL-6, total protein, albumin, total cholesterol, and hemoglobin concentration were determined in 164 blood samples from patients with prostate cancer. The body mass index and performance status were also determined., Results: The serum total protein, albumin, and cholesterol levels, hemoglobin levels, and body mass index of the patients whose serum IL-6 level was 7 pg/mL or greater were significantly lower (P <0.05) than the corresponding values in patients with a serum IL-6 level of less than 7 pg/mL. The serum IL-6 level of patients with a serum albumin level of less than 3.5 g/dL, serum total protein level of less than 7.0 g/dL, serum total cholesterol level of less than 180 mg/dL, hemoglobin level of less than 11.0 g/dL, and body mass index of less than 21 kg/m2 were significantly greater (P <0.05) than the values in their respective counterparts. A significant correlation was found between the elevation of serum IL-6 and performance status (P <0.05). The mortality rate of patients with greater serum IL-6 levels was significantly greater than that of those with lower serum IL-6 levels in patients with untreated disease, patients in remission, and patients with relapse (all P <0.05)., Conclusions: These findings suggest that IL-6 may be one of the factors contributing to the complex syndrome of cachexia in patients with prostate cancer (all P <0.05).
- Published
- 2007
- Full Text
- View/download PDF
14. Usefulness of alpha1-antichymotrypsin-PSA complex for predicting bone metastases of prostate cancer.
- Author
-
Kikuchi E, Nakashima J, Ishibashi M, Ohigashi T, Oya M, Nakagawa K, Miyajima A, and Murai M
- Subjects
- Aged, Aged, 80 and over, Humans, Male, Middle Aged, Multiprotein Complexes blood, Predictive Value of Tests, Bone Neoplasms secondary, Prostate-Specific Antigen blood, Prostatic Neoplasms blood, Prostatic Neoplasms pathology, alpha 1-Antichymotrypsin blood
- Abstract
Objectives: To determine the usefulness of alpha1-antichymotrypsin-prostate-specific antigen (PSA) complex (PSA-ACT)-based parameters in predicting bone metastasis in patients with prostate cancer., Methods: PSA-ACT, total PSA, free PSA, their volume-adjusted values, and alkaline phosphatase were evaluated in 220 consecutive patients with newly diagnosed prostate cancer., Results: Bone metastases were detected by bone scan in 27 (12.3%) of the 220 patients. The serum levels of PSA-ACT, total PSA, free PSA, PSA density, PSA adjusted for transition zone volume, PSA-ACT density, PSA-ACT adjusted for transition zone volume, alkaline phosphatase, PSA-ACT/PSA ratio, and Gleason score in patients with bone metastases were each significantly greater than in those without bone metastases. On receiver operating characteristic analyses, PSA-ACT had the greatest area under the curve (0.88), but the receiver operating characteristic curve demonstrated that the sensitivity and specificity of PSA-ACT were marginally better than those of total PSA at only a few selected cutoff points. At a sensitivity of 93% (2 patients with bone metastasis missed), unnecessary bone scans would have been avoided in 107 and 102 patients using a PSA-ACT cutoff value of 10 ng/mL and total PSA cutoff value of 11.5 ng/mL, respectively. Multivariate logistic regression analysis demonstrated that PSA-ACT and Gleason score were significant independent predictors of bone metastasis., Conclusions: PSA-ACT is as useful as total PSA for identifying patients with a low probability of having bone metastasis. PSA-ACT could replace PSA for predicting negative bone scans in a clinical setting in which PSA-ACT is used for monitoring and screening patients for prostate cancer.
- Published
- 2006
- Full Text
- View/download PDF
15. Efficacy compared between caudal block and periprostatic local anesthesia for transrectal ultrasound-guided prostate needle biopsy.
- Author
-
Horinaga M, Nakashima J, and Nakanoma T
- Subjects
- Aged, Humans, Male, Ultrasonography, Anesthesia, Caudal, Anesthesia, Local, Anesthetics, Local therapeutic use, Biopsy, Needle adverse effects, Biopsy, Needle methods, Lidocaine therapeutic use, Nerve Block, Pain etiology, Pain prevention & control, Prostate diagnostic imaging, Prostate pathology
- Abstract
Objectives: To investigate the clinical efficacy of a caudal block compared with periprostatic local anesthesia for transrectal ultrasound-guided multicore prostate needle biopsy., Methods: A total of 100 patients who had undergone initial prostate biopsy using a systematic five-region biopsy by a single operator were investigated. The patients were randomly divided into two groups, with each group receiving a different anesthetic modality before biopsy. Group 1 received periprostatic local anesthesia and group 2 received a caudal block. Both groups received 10 mL 1% lidocaine before biopsy. A 10-point visual analog scale was used to assess patient pain and anxiety. The duration between anesthesia induction and the beginning of the biopsy was measured., Results: Patients who received local anesthesia (group 1) reported significantly less pain immediately after biopsy, with an average score of 1.1 compared with 2.1 in group 2 (caudal block, P = 0.01). Both groups were comparable regarding age, prostate-specific antigen level, digital rectal examination findings, prostate size, number of biopsy cores, level of prebiopsy anxiety, body mass index, and histologic findings. Group 1 required a significantly shorter period of anesthesia (198.5 seconds) than did group 2 (594.5 seconds, P <0.0001). No anesthetic-related side effects occurred in either group., Conclusions: The results of our study have shown that the caudal block provides less effective anesthesia than periprostatic local anesthesia with the same dose of lidocaine for prostate biopsy. We have concluded that local anesthesia is a safe, simple, and rapid method of pain relief during prostate biopsy.
- Published
- 2006
- Full Text
- View/download PDF
16. Clinical and pathologic significance of activation of signal transducer and activator of transcription 3 in prostate cancer.
- Author
-
Horinaga M, Okita H, Nakashima J, Kanao K, Sakamoto M, and Murai M
- Subjects
- Aged, Humans, Male, Middle Aged, Neoplasm Invasiveness, Prostatic Neoplasms genetics, STAT3 Transcription Factor genetics, Prostatic Neoplasms chemistry, Prostatic Neoplasms pathology, STAT3 Transcription Factor analysis
- Abstract
Objectives: To evaluate the association of signal transducer and activator of transcription 3 (STAT3) with the invasiveness and aggressiveness of localized prostate cancer., Methods: Paraffin-embedded specimens from 92 patients with clinically localized prostate cancer who underwent radical prostatectomy without neoadjuvant treatment were analyzed by immunohistochemistry using two antibodies: anti-phospho-specific STAT3 (p-STAT3) antibody, which recognized only activated STAT3, and anti-total STAT3 antibody, which recognized both activated and inactivated STAT3. The patients were separated into one of four groups according to the percentage of the cells with positive nuclear staining using a 0 to 3+ scoring system. The associations between the immunostaining and invasiveness and aggressiveness of clinically localized prostate cancer were analyzed., Results: Pathologically, 66 patients (71.7%) had organ-confined disease. Of the 92 tumors examined, 8, 20, 23, and 41 showed staining patterns for p-STAT3 of 0, 1+, 2+, and 3+, respectively. In addition, 0, 3, 2, and 87 tumors showed staining patterns for STAT3 of 0, 1+, 2+, and 3+, respectively. The staining patterns for p-STAT3 correlated significantly with pathologic stage, Gleason score, and extracapsular extension. No significant correlation was found between p-STAT3 immunostaining and microvascular invasion, perineural invasion, or seminal vesicle invasion. Patients with 3+ immunostaining of p-STAT3 had a significantly greater biochemical prostate-specific antigen failure rate than those with 2+ or less immunostaining., Conclusions: Increased p-STAT3 immunoreactivity showed a highly invasive and aggressive potential in patients with localized prostate cancer treated with radical prostatectomy. This suggests that STAT3 signaling contributes to the invasiveness and aggressiveness of prostate cancer.
- Published
- 2005
- Full Text
- View/download PDF
17. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer.
- Author
-
Nakashima J, Tanimoto A, Imai Y, Mukai M, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, and Murai M
- Subjects
- Adenocarcinoma surgery, Aged, Humans, Male, Middle Aged, Neoplasm Invasiveness, Predictive Value of Tests, Preoperative Care, Prostatectomy, Prostatic Neoplasms surgery, Rectum, Seminal Vesicles pathology, Sensitivity and Specificity, Adenocarcinoma pathology, Magnetic Resonance Imaging methods, Neoplasm Staging methods, Prostatic Neoplasms pathology
- Abstract
Objectives: To assess the value of endorectal magnetic resonance imaging (MRI) for detecting the tumor site, tumor size, and disease extent in patients with localized prostate cancer., Methods: The MRI findings were compared with the histopathologic findings of radical prostatectomy specimens in 95 patients., Results: The histologic examination revealed 186 cancer foci. Endorectal MRI detected 109 cancer foci. The accuracy, sensitivity, and positive predictive value of endorectal MRI for detecting tumor foci greater than 1.0 cm in diameter was 79.8%, 85.3%, and 92.6%, respectively; the corresponding value for detecting tumor foci smaller than 1.0 cm was 24.2%, 26.2%, and 75.9%, respectively. The maximal tumor diameter on endorectal MRI correlated with that shown by histologic examination for tumors larger than 1.0 cm in diameter. However, it did not correlate significantly with the histologic diameter of tumors smaller than 1.0 cm. The accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of endorectal MRI was 74.7%, 57.1%, 82.1%, 57.1%, and 82.1%, respectively, for the detection of extracapsular extension and was 75.8%, 62.1%, 81.8%, 60.0%, and 83.1%, respectively, for local staging., Conclusions: The results of the present study suggest that endorectal MRI is useful for predicting local extension, as well as tumor site and tumor size, of cancer foci greater than 1.0 cm in diameter.
- Published
- 2004
- Full Text
- View/download PDF
18. Differential expression of activator protein-2 isoforms in renal cell carcinoma.
- Author
-
Oya M, Mikami S, Mizuno R, Miyajima A, Horiguchi Y, Nakashima J, Marumo K, Mukai M, and Murai M
- Subjects
- Adenocarcinoma genetics, Adenocarcinoma metabolism, Adenocarcinoma, Clear Cell genetics, Adenocarcinoma, Clear Cell metabolism, Carcinoma, Papillary genetics, Carcinoma, Papillary metabolism, Carcinoma, Renal Cell metabolism, DNA-Binding Proteins analysis, DNA-Binding Proteins genetics, ErbB Receptors analysis, Gene Expression Regulation, Neoplastic, Humans, Kidney Neoplasms metabolism, Kidney Tubules metabolism, Neoplasm Proteins analysis, Neoplasm Proteins genetics, Neoplasm Staging, Protein Isoforms analysis, Protein Isoforms biosynthesis, Protein Isoforms genetics, Receptor, ErbB-2 analysis, Transcription Factor AP-2, Transcription Factors analysis, Transcription Factors genetics, Carcinoma, Renal Cell genetics, DNA-Binding Proteins biosynthesis, Kidney Neoplasms genetics, Neoplasm Proteins biosynthesis, Transcription Factors biosynthesis
- Abstract
Objectives: To investigate the expression of activator protein-2 (AP-2) in renal cell carcinoma (RCC) by immunohistochemistry. Three AP-2 isoforms alpha (alpha), beta (beta), and gamma (gamma) are known to exhibit a highly homologous structure; however, their functions are considered to be different. AP-2 has been implicated to play a role in carcinogenesis, as well as in the development of the kidney., Methods: The expression of the three AP-2 isoforms, alpha, beta, and gamma, was determined in 58 patients with RCC by immunohistochemistry. Epidermal growth factor receptor and erbB2 expression in 42 patients with RCC was also evaluated to investigate the correlation with AP-2 isoforms., Results: AP-2 isoforms are differentially expressed in normal renal tubules. Of 58 RCC tissue specimens, 15 (25.9%) demonstrated nuclear and cytoplasmic expression of AP-2alpha. Clear cell RCC had a significantly greater rate of AP-2alpha expression than the nonclear subtypes (14 of 41 clear versus 1 of 17 nonclear subtypes). Of the 58 specimens, 8 (13.8%) showed nuclear staining for AP-2beta; notably, localized small cases had a significantly greater rate of nuclear staining for AP-2beta (5 of 13 in pT1a versus 3 of 45 in pT1b or greater). In addition, only 2 cases (3.5%) demonstrated nuclear staining for AP-2gamma. Epidermal growth factor receptor and erbB2 expression did not correlate with expression of the AP-2 isoforms., Conclusions: AP-2 isoforms were differentially expressed in RCC, as well as in the adult normal kidney. AP-2alpha was dominantly expressed in clear cell RCC. AP-2beta expression was observed in the low-stage subtypes of RCC, and this transcription factor may be related to early carcinogenesis.
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.